Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma
Erin F. Simonds, Edbert D Lu, O. Badillo, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 6, pp. e002181-e002181
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy
Fatima Khan, Lizhi Pang, Madeline Dunterman, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 1
Open Access | Times Cited: 187
Tumor microenvironment signaling and therapeutics in cancer progression
Anshika Goenka, Fatima Khan, Bhupender Verma, et al.
Cancer Communications (2023) Vol. 43, Iss. 5, pp. 525-561
Open Access | Times Cited: 122
TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma
Rui Sun, Rowland H. Han, Colin McCornack, et al.
Science Advances (2023) Vol. 9, Iss. 19
Open Access | Times Cited: 52
Adaptive design of mRNA-loaded extracellular vesicles for targeted immunotherapy of cancer
Shiyan Dong, Xuan Liu, Ye Bi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 49
Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion
Ke-Xun Yu, Weijie Yuan, Huizhen Wang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 6
Open Access | Times Cited: 17
Peripheral Blood-Based Biomarkers for Immune Checkpoint Inhibitors
Ho Jung An, Hong Jae Chon, Chan Kim
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9414-9414
Open Access | Times Cited: 72
Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities
Johannes K. Andersen, Hrvoje Miletić, Jubayer A. Hossain
Cancers (2022) Vol. 14, Iss. 5, pp. 1319-1319
Open Access | Times Cited: 64
Impact of epigenetic reprogramming on antitumor immune responses in glioma
Brandon L. McClellan, Santiago Haase, Felipe J. Núñez, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 2
Open Access | Times Cited: 38
Next-generation antigen-presenting cell immune therapeutics for gliomas
Catalina Lee-Chang, Maciej S. Lesniak
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 30
Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
Shumin Xu, Chenyang Wang, Lingge Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Abnormal Vessels Potentially Accelerate Glioblastoma Proliferation by Inducing the Protumor Activation of Macrophages
Hiroaki Matsuzaki, Keitaro Kai, Yoshihiro Komohara, et al.
Cancer Science (2025)
Open Access | Times Cited: 1
PP2Ac/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophages
Winson S. Ho, Isha Mondal, Beisi Xu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 6
Open Access | Times Cited: 20
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial
Hongnan Mo, Yongpei Yu, Xiaoying Sun, et al.
Nature Medicine (2024) Vol. 30, Iss. 9, pp. 2528-2539
Closed Access | Times Cited: 7
Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma
Pavlina Chuntova, Akane Yamamichi, Tiffany Chen, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 5, pp. e004644-e004644
Open Access | Times Cited: 26
The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implications
Syed Mohd Faisal, Andrea Comba, María L. Varela, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 24
Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma
Aimée du Chatinier, Michaël H. Meel, Arvid I Das, et al.
Neuro-Oncology Advances (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 21
Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities
Amanda Johnson, John Laterra, Hernando López-Bertoni
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 21
Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions
Jing Zhou, Luohong Li, Minqi Jia, et al.
Cancer Medicine (2022) Vol. 12, Iss. 6, pp. 7207-7221
Open Access | Times Cited: 21
The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma
Lingyun Zhang, Yu Jiang, Gao Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma
Bryan Gardam, Tessa Gargett, Michael P. Brown, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Basic Transcription Factor 3 Like 4 Enhances Malignant Phenotypes through Modulating Tumor Cell Function and Immune Microenvironment in Glioma
Bing Lu, Tianyi Lu, Jiawen Shi, et al.
American Journal Of Pathology (2024) Vol. 194, Iss. 5, pp. 772-784
Open Access | Times Cited: 4
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches
Maria Fortunata Lofiego, Francesca Piazzini, Francesca Pia Caruso, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Novel neutrophil targeting platforms in treating Glioblastoma: Latest evidence and therapeutic approaches
Rui Zhong, Hongmei He, X Wang
International Immunopharmacology (2025) Vol. 150, pp. 114173-114173
Closed Access
Development of Syngeneic Murine Glioma Models with Somatic Mismatch Repair Deficiency to Study Therapeutic Responses to Alkylating Agents and Immunotherapy
Deepti Bhatt, Ranjini K. Sundaram, Karla Alejandra Lopez, et al.
Current Protocols (2025) Vol. 5, Iss. 2
Closed Access
Cross-Talk Between Cancer and Its Cellular Environment—A Role in Cancer Progression
Eliza Turlej, Aleksandra Domaradzka, Justyna Radzka, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 403-403
Open Access
Page 1 - Next Page

Scroll to top